Skip to content

Drug interactions

Repotrectinib + Sertraline

Severity: Minor

Repotrectinib and Sertraline: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Repotrectinib is metabolized by CYP3A4, and sertraline is at most a weak inhibitor of this enzyme. Any increase in repotrectinib exposure is therefore expected to be small and is not clinically established. The labeling restriction applies to strong and moderate CYP3A inhibitors.

What this interaction means in plain words

Repotrectinib and Sertraline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Repotrectinib belongs to Oncology; Sertraline belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by sertraline may slightly raise repotrectinib exposure; clinical significance not established.

What to do

No dose change is generally needed. Monitor for repotrectinib adverse effects such as dizziness, ataxia and cognitive effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Repotrectinib and Sertraline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Repotrectinib with Sertraline?

MediHelp rates the interaction as minor. Repotrectinib and Sertraline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Repotrectinib is metabolized by CYP3A4, and sertraline is at most a weak inhibitor of this enzyme. Any increase in repotrectinib exposure is therefore expected to be small and is not clinically established. The labeling restriction applies to strong and moderate CYP3A inhibitors.

How serious is the interaction between Repotrectinib and Sertraline?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is generally needed. Monitor for repotrectinib adverse effects such as dizziness, ataxia and cognitive effects.

What other medicines interact with Sertraline?

MediHelp also lists interactions of Sertraline with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Sertraline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in